Synergy Rx Review
Best for: broadest drug catalog in the Lion MD white-label cluster
Synergy Rx (CareGLP platform, synergyrx.co) is a Wyoming-registered telehealth platform serving 50,000+ patients with compounded semaglutide ($199), tirzepatide ($349), and brand-name Ozempic ($499), Wegovy ($947), and Mounjaro ($947). Runs on the shared Lion MD clinician + 4-pharmacy network with Breeze Meds and Care Bare Rx.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Synergy Rx is a solid telehealth option with balanced features and pricing.
Score Breakdown
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Injection | compounded | $199 |
| Injection | compounded | $349 |
| Oral | compounded | $299 |
| Oral | compounded | $399 |
| Ozempic | brand | $499 |
| Wegovy | brand | $947 |
✓ Pros
- •Broad drug catalog: compounded sema/tirz in both injection and oral dissolving tablet formats, plus brand-name Ozempic, Wegovy, and Mounjaro
- •Claims 50,000+ patients per homepage as of late 2025
- •All 50 US states subject to state telehealth regulations
- •Same named medical team as Breeze Meds and Care Bare Rx (Dr. Carr and Dr. Tenbrink via Lion MD)
- •Four named 503A pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma Rx)
- •LegitScript seal displayed in footer
✗ Cons
- •Runs on the same Lion MD clinician network and the same 4 compounding pharmacies as Breeze Meds and Care Bare Rx — the three brands are white-labeled storefronts on top of one underlying operation
- •Mandatory individual arbitration + class action waiver in ToS (30-day opt-out window from signup)
- •Consultation fees are non-refundable and all prescription sales are final per ToS
- •Platform explicitly disclaims liability for third-party pharmacy medication quality: 'SynergyRx makes no representations or warranties regarding the efficacy, safety, or outcomes of any medication provided through these third parties'
- •State availability is 'subject to each state's telehealth and prescribing regulations' — the full list of active states requires contacting customer service rather than being published
- •Do NOT confuse with the unrelated 'Synergy Rx Pharmacy' (San Diego, CA) that issued a voluntary nationwide recall in February 2017 for non-sterile compounded products — that is a different entity in a different state
- •Do not visit synergyrx.com — it is a parked domain on Sedo and unrelated to the telehealth brand. The correct domain is synergyrx.co
Ready to start with Synergy Rx?
Starting at $199/month. See current pricing and start your free consultation.
Sources & methodology
Our Synergy Rx review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of April 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Synergy Rx
Alan Meds
Best for: budget-conscious shoppers
Editorial score · methodology
Amazon Pharmacy
Best for: fastest brand-name Foundayo delivery with the cheapest insured price
Editorial score · methodology
AmberHealth
Best for: budget-conscious shoppers
Editorial score · methodology
Frequently Asked Questions
Ready to start with Synergy Rx?
Starting at $199/month. See current pricing and start your free consultation.